studies on the in vitro phototoxicity of the antidiabetes drug gliclazide.

studies on the in vitro phototoxicity of the antidiabetes drug gliclazide.

;Verónica López;Tamara Zoltan;Carla Izzo;Franklin Vargas
drug testing and analysis 2006 Vol. 1 pp. 3-12
215
lpez2006avancesstudies

Abstract

The phototoxic antidiabetes drug gliclazide (1) is photolabile under aerobic conditions and UV-B light.Irradiation of a phosphate buffered solution of 1 under oxygen atmosphere produces two photoproducts.The photochemistry of 1 involves cleavage of the S-N and C(O)-N bonds of the urea unit. Red blood celllysis photosensitized by 1 was demonstrated. Their photoproducts didn't show this effect. Inhibition ofthis process by addition of DABCO, GSH, confirmed the possibility of the participation of free radicalsin the photoinduced hemolysis. Furthermore, in a lipid-photoperoxidation test with linoleic acid the invitro phototoxicity of gliclazide was also verified. The generation of singlet oxygen during the photolysisof gliclazide was ruled out by means of the histidine and NaN3 assays. In a supplementary study theability of 1 to inhibit free radical or reactive oxygen species (.OH, 1O2, H2O2) generated in cell-freesystems was investigated using chemiluminescence and electronic absorption spectra.

Citation

ID: 184900
Ref Key: lpez2006avancesstudies
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
184900
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet